Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
Glioblastoma multiforme (GBM) is one of the most lethal forms of primary brain tumors. Glioblastoma stem cells (GSCs) play an undeniable role in tumor development by activating multiple signaling pathways such as Wnt/β-catenin and PI3K/AKT/mTOR that facilitate brain tumor formation. CD133, a transme...
Main Authors: | Amir Barzegar Behrooz, Amir Syahir |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.642719/full |
Similar Items
-
Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
by: Christine A. Fargeas, et al.
Published: (2021-08-01) -
Wnt/β-Catenin Signaling Exacerbates Keloid Cell Proliferation by Regulating Telomerase
by: Dongmei Yu, et al.
Published: (2016-10-01) -
Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
by: Chen W, et al.
Published: (2018-07-01) -
WNT Signaling as a Therapeutic Target for Glioblastoma
by: Michael Latour, et al.
Published: (2021-08-01) -
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p
by: Yang Zhou, et al.
Published: (2019-12-01)